Congo begins Ebola vaccine trial despite embedded outbreak
A pivotal trial of vaccines against the strain of Ebola that is driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo, where the epidemic originated and the vast majority of cases and deaths have occurred. The first participant was vaccinated on Friday in Bunia, eastern Congo, with Merck & Co.’s Ervebo shot, which has been approved to guard against a different Ebola species. An experimental alternative developed specifically against Bundibugyo by Moderna...
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
[Claude] Report 2 covers the same DR Congo Bundibugyo Ebola vaccine trial launch as Report 1, with no conflicting facts stated.
8h ago[Claude] Both reports cover the start of the Ebola vaccine trial in the DRC amid the outbreak, with Report 2 describing it as expected shortly, which is a timing difference rather than a contradiction.
1d agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this